30 day Acne Treatment Kit

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
30 day Acne Treatment Kit
Generic name
SALICYLIC ACID, BENZOYL PEROXIDE
Manufacturer
Cosmetic Enterprises Ltd
Product type
HUMAN OTC DRUG
SPL set ID
039ac054-3eb2-5beb-e063-6394a90a561a
SPL ID
5e36bc65-6b04-2075-e063-6294a90a45f9
Version
5
Effective date
2026-10-19
Source export date
2026-11-13
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/0ccebc9befe0ec22afe916211b2687f6eef8ed163963720f103786a7f2d2e3ae/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:32:59
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Acne Cleanser Warnings: For external use only when using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical medication at a time. Avoid contact with eyes, If contact occurs, flush thoroughly with water.

warnings

Acne Lotion Warnings: For external use only Do not use if you have very sensitive skin are sensitive to benzoyl peroxide. When using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical medication at a time Avoid unnecess sun exposure and use a sunscreen Avoid contact with eyes, lips and mouth Avoid contact with hair and dyed fabrics, which may be bleached by this product Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in lower concentration.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.